Norgestimate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Norgestimate
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Norgestimate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 10 USDMF, 6 CEP/COS, 4 NDC API, 7 Listed Suppliers, $ API Reference Price

18 API Suppliers
10 USDMF
6 CEP/COS
4 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

64 FDF Dossiers, 40 FDA Orange Book, 18 Canada, 3 South Africa, 3 Listed Dossiers

64 FDF Dossiers
40 FDA Orange Book
18 Canada
3 South Africa
3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

DIGITAL CONTENT

13 News #PharmaBuzz

13 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 5 Others

2 EDQM
5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 11,904 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 4Janssen Inc.

02 1Searchlight Pharma Inc.

03 1Triton Pharma Inc.

filter Patent Reset all filters

6 All

01 11332228

02 12267743

03 22356747

04 22431521

filter Product Reset all filters

6 All

01 217B-Estradiol & 17B-Estradiol | Norgestimate

02 4Norgestimate | Ethinyl Estradiol

filter Dosage Reset all filters

6 All

01 6Tablet

filter Exp Date Reset all filters

6 All

01 12011-10-04

02 12019-04-01

03 22019-12-08

04 22021-12-13

Product Main Page

01

Janssen Inc.

Norgestimate, Ethinyl Estradiol

World Drug Safety EU

Not Confirmed

Janssen Inc.

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-12-08

Date Granted : 2005-09-27

Norgestimate, Ethinyl Estradiol

Brand Name : TRI-CYCLEN LO

Patent Number : 2356747

Filing Date : 1999-12-08

Strength per Unit : 0.180, 0.215, 0.250mg / 0.025mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-08

Date Granted : 2005-09-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Janssen Inc.

Norgestimate, Ethinyl Estradiol

World Drug Safety EU

Not Confirmed

Janssen Inc.

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-12-08

Date Granted : 2005-09-27

Norgestimate, Ethinyl Estradiol

Brand Name : TRI-CYCLEN LO

Patent Number : 2356747

Filing Date : 1999-12-08

Strength per Unit : 0.180, 0.215, 0.250mg / 0.025mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-12-08

Date Granted : 2005-09-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Janssen Inc.

Norgestimate, Ethinyl Estradiol

World Drug Safety EU

Not Confirmed

Janssen Inc.

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-13

Date Granted : 2013-04-16

Norgestimate, Ethinyl Estradiol

Brand Name : TRI-CYCLEN LO

Patent Number : 2431521

Filing Date : 2001-12-13

Strength per Unit : 0.180, 0.215, 0.250mg / 0.025mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-12-13

Date Granted : 2013-04-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Janssen Inc.

Norgestimate, Ethinyl Estradiol

World Drug Safety EU

Not Confirmed

Janssen Inc.

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-12-13

Date Granted : 2013-04-16

Norgestimate, Ethinyl Estradiol

Brand Name : TRI-CYCLEN LO

Patent Number : 2431521

Filing Date : 2001-12-13

Strength per Unit : 0.180, 0.215, 0.250mg / 0.025mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-12-13

Date Granted : 2013-04-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Searchlight Pharma Inc.

17B-Estradiol & 17B-Estradiol, Norgestimate

World Drug Safety EU

Not Confirmed

Searchlight Pharma Inc.

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-04-01

Date Granted : 2011-07-26

17B-Estradiol & 17B-Estradiol, Norgestimate

Brand Name : PREFESTA

Patent Number : 2267743

Filing Date : 1999-04-01

Strength per Unit : 1.0mg / 1.0mg / 0.09mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-04-01

Date Granted : 2011-07-26

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

06

Triton Pharma Inc.

17B-Estradiol & 17B-Estradiol, Norgestimate

World Drug Safety EU

Not Confirmed

Triton Pharma Inc.

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-10-04

Date Granted : 1994-10-04

17B-Estradiol & 17B-Estradiol, Norgestimate

Brand Name : PREFESTA

Patent Number : 1332228

Filing Date : 1987-09-24

Strength per Unit : 1.0mg / 1.0mg / 0.09mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-10-04

Date Granted : 1994-10-04

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!